Gaita F, Richiardi E, Giustetto C, Bocchiardo M, Scaglione M, Zola G, Libero L, Riccardi R
Divisione di Cardiologia, Ospedale Civile di Asti.
G Ital Cardiol. 1992 Nov;22(11):1245-53.
Fifty-two patients with Wolff-Parkinson-White syndrome underwent transcatheter ablation. All patients were symptomatic. Eighteen had documented episodes of atrial fibrillation, 14 of which also had reentrant tachycardias; the remaining 34 had only episodes of reentrant tachycardias. Forty-nine patients had both anterograde and retrograde conduction through the accessory pathway; 3 had retrograde conduction alone; 2 patients had 2 accessory pathways and 1 had 3. All patients were resistant or intolerant to at least 2 antiarrhythmic drugs.
All patients were treated with radiofrequency current. Ablation was considered successful if the anterograde and retrograde conduction were completely abolished. Ablation was considered unsuccessful if ablation of only 1 pathway in patients with 2 or more accessory pathways and/or modification of the accessory pathway conduction without interruption was achieved.
Accessory pathway ablation was successfully performed in 46 out of 52 patients (88%). Fifty out of 56 accessory pathways were effectively ablated (89%). Thirty-eight required a single session of ablation and 8 additional patients were successfully ablated during a second session. The number of radiofrequency current applications ranged from 2 to 13 (mean 4.1 +/- 2.5). The mean duration of the sessions was 4.30 +/- 1.50 hours (range 2.30 to 9). The mean radiation exposure for session was 55 +/- 25 minutes (range 20 minutes to 2.30 hours). Complications were observed in 2 out of 52 patients. One patient had a transient II degree type 1 atrioventricular block; another patient with severe arterial hypertension had a mild hemorrhagic stroke with complete neurological remission. FOLLOW-UP. Forty-five out of the 46 patients in whom ablation was successful were asymptomatic for arrhythmias during a mean follow-up of 8 months (range 4 to 16), without antiarrhythmic treatment, and without reappearance of preexcitation. One patient showed reappearance of preexcitation at electrocardiogram one month after the ablation, followed by an episode of reentrant tachycardia; this patient underwent a second successful ablation session.
Our results show that ablation techniques have high success rates with no serious complications.
52例预激综合征患者接受了经导管消融治疗。所有患者均有症状。18例有房颤发作记录,其中14例同时有折返性心动过速;其余34例仅有折返性心动过速发作。49例患者经旁路同时存在前向和逆向传导;3例仅有逆向传导;2例患者有2条旁路,1例有3条旁路。所有患者对至少2种抗心律失常药物耐药或不耐受。
所有患者均接受射频电流治疗。如果前向和逆向传导完全消除,则认为消融成功。如果在有2条或更多旁路的患者中仅消融1条旁路和/或在未中断的情况下改变旁路传导,则认为消融失败。
52例患者中有46例(88%)成功进行了旁路消融。56条旁路中有50条(89%)被有效消融。38例患者单次消融成功,另外8例患者在第二次消融时成功。射频电流应用次数为2至13次(平均4.1±2.5次)。手术平均持续时间为4.30±1.50小时(范围2.30至9小时)。每次手术的平均辐射暴露时间为55±25分钟(范围20分钟至2.30小时)。52例患者中有2例出现并发症。1例患者出现短暂的I度I型房室传导阻滞;另1例患有严重动脉高血压的患者发生轻度出血性中风,神经功能完全恢复。随访:46例消融成功的患者中有45例在平均8个月(范围4至16个月)的随访期间无心律失常症状,未接受抗心律失常治疗,且预激未再出现。1例患者在消融术后1个月心电图显示预激再现,随后发生一次折返性心动过速;该患者接受了第二次成功的消融手术。
我们的结果表明,消融技术成功率高,无严重并发症。